Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.
about
Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicityOffsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure?Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.Impact of cigarette smoke extract and hyperglycemic conditions on blood-brain barrier endothelial cells.Junctional proteins of the blood-brain barrier: New insights into function and dysfunction.HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.Hyperglycemia exacerbates antiretroviral drug combination induced blood-brain barrier endothelial toxicity.New experimental models of the blood-brain barrier for CNS drug discovery.Hyperbaric oxygen preconditioning ameliorates hypoxia-ischemia brain damage by activating Nrf2 expression in vivo and in vitro.Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10?Brain ischemic preconditioning protects against ischemic injury and preserves the blood-brain barrier via oxidative signaling and Nrf2 activation.In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity
P2860
Q29247988-F3E1F90A-3F2D-4D9E-8366-826DABBD5981Q33825485-50D8E026-73DD-452A-AFFB-9AAF210E2EBCQ34504916-FBE496DE-19E1-4318-844E-26AE0390DED6Q35685226-0B015700-E607-494D-9487-81224C01AB76Q35884677-A6A71531-669E-48E3-A0C8-7E6A694742F2Q36812374-C536DE86-0974-443C-BF9A-E5D1AF7225D1Q37199557-655ED081-1013-4458-AC97-6B30DB711C24Q38762179-F7C20DBE-3E12-4CF4-9B3B-F759E4EA8228Q38991126-3F3838F0-AAC5-4AEE-A668-BAE6D42B7F1EQ46615362-DC1341FD-C543-4D27-B95D-0A1C35D134D9Q50964354-B7DCF681-6920-40E6-B510-95D9B809254DQ54108837-178FF5B6-D779-4DF1-9117-866EEFB498E2Q58714736-1D3EDF27-B448-475F-9C02-F6F4AA9FB5B8
P2860
Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@ast
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@en
type
label
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@ast
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@en
prefLabel
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@ast
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@en
P2860
P921
P1433
P1476
Altered Nrf2 signaling mediate ...... othelial dysfunction in vitro.
@en
P2093
Luca Cucullo
Ravi K Sajja
P2860
P304
P356
10.1371/JOURNAL.PONE.0122358
P407
P577
2015-03-25T00:00:00Z